no statement of use filed
on 26 Feb 2024
Last Applicant/ Owned by
C/O BAUDAX BIO, INC., 490 LAPP ROAD
MALVERN
PA
19355
Serial Number
90175249 filed on 11th Sep 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactRead More
Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy
Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; scientific and medical research consultancy relating to all the aforesaid services
Custom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals
Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy
No 90175249
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Feb 2024 | ABANDONMENT - NO USE STATEMENT FILED |
26th Feb 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
05th Oct 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
05th Oct 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
05th Oct 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
05th Oct 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
05th Oct 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
05th Oct 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
26th Jul 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
22nd Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |